Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large <scp>B</scp>‐cell lymphoma in the rituximab eraReina Watanabe, Yoshiaki Ishigatsubo, Naoto Tomita et al.|European Journal Of Haematology|2013Cited by 58
European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patientsEri Yamamoto, Yoshiaki Ishigatsubo, Katsumichi Fujimaki et al.|Cancer Science|2013Cited by 39
Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapyKazuho Miyashita, Yoshiaki Ishigatsubo, Naoto Tomita et al.|Leukemia Research|2015Cited by 35
Clinical Significance of Serum Ferritin at Diagnosis in Patients With Acute Myeloid Leukemia: A YACHT Multicenter Retrospective StudyTakayoshi Tachibana, Hideaki Nakajima, Taiki Andou et al.|Clinical Lymphoma Myeloma & Leukemia|2018Cited by 28
Prognostic significance of serum beta-2 microglobulin level in Hodgkin lymphoma treated with ABVD-based therapyYuki Nakajima, Yoshiaki Ishigatsubo, Naoto Tomita et al.|Medical Oncology|2014Cited by 15